NEW YORK ( TheStreet) -- This article is the first of a series that will give you further information on stocks that are highly rated by TheStreet staff. During the last 40 years I have reviewed many rating systems, some which led me to follow stocks I might have otherwise overlooked. Most lists cannot address the widely different investment needs and risk tolerances of the individual investor.
Before you start using any rating list you need to first identify whether you are a growth, value, income or momentum investor. A stock that might be suitable for your tax-deferred IRA may be totally unsuitable for your taxable accounts. Here is a link to a video I made that further explains some investment issues: The 3 Stages of Investing.
This series is designed to expand on each highly rated issue to give you additional information to make an informed decision whether this highly rated stock might be suitable for your own portfolio.
Abbott Laboratories (ABT) has been given an A+ rating by the staff of TheStreet. Recently the stock has been a little flat and about a month ago was trading at close to the same price it trades today.The good news is that over the past six months Abbot Labs has outpaced the overall market as measured by the Value Line Index. While the Index is down 2% of the period Abbott Labs is up 9%: Abbott engages in the discovery, development, manufacture and sale of health care products worldwide. The company primarily serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. Abbott was founded in 1888 and is headquartered in Abbott Park, Ill.
Factors to ConsiderBarchart technical indicators: The stock rates a 56% Barchart technical buy signal as well as a Trend Spotter buy signal. It trades above its 20-, 50- and 100-day moving averages. Although the stock had six up days in the last month, it is trading up .81% for the period. During the last quarter it hit 18 new highs and is up 5.93% for that period. The stock price increased by 31.45% over the past year and has a Relative Index of 53.66%.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV